Home > Boards > US Listed > Biotechs >

Avid Bioservices Inc. (CDMO)

CDMO RSS Feed
Add CDMO Price Alert      Hide Sticky   Hide Intro
Moderator: cjgaddy, 4OurRetirement
Search This Board: 
Last Post: 4/5/2020 6:51:45 PM - Followers: 830 - Board type: Free - Posts Today: 4


Avid Bioservices, Inc. (Nasdaq “CDMO”), Tustin CA. http://www.avidbio.com
Four Avid Fact Sheets a/o 8-9-18: https://avidbio.com/publications/brochures/
Avid Bioservices is a CDMO committed to improving the lives of patients by manufacturing products derived from mammalian cell culture for the biotechnology & biopharmaceutical industries. Services include cGMP clinical & commercial product manufacturing, purification, bulk packaging, stability testing & regulatory strategy, submission, and support. The company also provides a variety of process development activities, including cell line development & optimization, cell culture & feed optimization, analytical methods development, and product characterization.

UPCOMING EVENTS: http://ir.avidbio.com/events-and-presentations
Mar10: Q3/FY20 (q/e 1-31-20) Financials & Conf. Call => PR+Transcript: https://tinyurl.com/s9cmzmf
Mar23-26: DCAT Week, NYC
Apr28-30: Interphex, NYC
Jun8-11: BIO Intl. Convention, SanDiego
~Jun25: Q4/FY20 (fy/e 4-30-20) Financials & Conf. Call


Quotes: Yahoo: Yahoo.com/CDMO Nasdaq: http://www.nasdaq.com/symbol/cdmo RT: http://www.nasdaq.com/symbol/cdmo/real-time
IR: Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 sdiaz@vidasp.com, Tim Brons (Media) 415-675-7402 tbrons@vidasp.com

SEC:
Latest 10K 4-30-19 iss. 6-27-19 http://tinyurl.com/yxukx6t4 (Cash 4-30-19=$32.4mm)
Latest 10Q 1-31-20 iss. 3-10-20 https://tinyurl.com/vkocrsg (Cash 1-31-20=$30.7mm)
ALL SEC filings for CDMO: https://tinyurl.com/yc4zjyzv
CDMO's Corp. Bylaws (a/o 11-14-14): http://tinyurl.com/y8hsppea - Latest 14A/Proxy: https://tinyurl.com/y7qprpg9 (12-7-17)
Poison Pill adopted 3-16-06 for 10yrs: http://tinyurl.com/yvypvh 44-pg SEC filing: http://tinyurl.com/5m57ut BUNGLER explains in plain language: http://tinyurl.com/mft4nd6
...3-17-16 Poison Pill extended until 3-16-2021 https://tinyurl.com/y74glo2n (Form8A Amendment #1)
...Poison Pill TERMINATED eff. 9-23-2019 https://tinyurl.com/y2mzx3xo

SHARES:
Shares O/S as of 3-2-20=56,482,154 - history since 4-2006: https://tinyurl.com/s9cmzmf
...A/O 1-31-20: 2,941,000 stock options outstanding at a wgt.avg. exercise price of $6.45 (pg.15 10Q).
1-12-18: S-3 Shelf Registration filed for up to $125mm https://tinyurl.com/y9qtewpw
...2-20-18: Avid Raises ~$21.8M net, selling 10,294,445@$2.25 (underwriter: Wells Fargo) 8-K: https://tinyurl.com/ya3nenth 424B5: https://tinyurl.com/ycpshgxl
Total INST.+LARGE Holdings: 37,448,204 66.6% a/o 9-30-19 - See https://tinyurl.com/wyth24y

9 LARGEST SHAREHOLDERS a/o 9-30-19:

1. Tappan Street (Prasad Phatak): 4,854,100 8.6% (+337,993 a/o 12-31-18 13G: http://tinyurl.com/yxrpla3b )
2. IsZo Capital Mgt. (Brian Sheehy): 4,534,694 8.1% (-243,429 a/o 9-30-19 Nasdaq Inst.)
3. Eastern Capital (Kenneth Dart): 4,300,992 7.6% (a/o 12-7-17 14A: https://tinyurl.com/y7qprpg9 acq. 10-2015)
4. Blackrock Inc. (Larry Fink): 3,925,526 7.0% (+135,240 q/e 9-30-19 Nasdaq Inst.)
5. Ronin Trading (John Stafford III+Roger Farley): 2,638,450 4.8% (a/o 4-17-18 13D: https://tinyurl.com/ycf7d2uk )
6. Vanguard Group 2,676,002 4.8% (+3,417 q/e 9-30-19 Nasdaq Inst.)
7. Snyder Capital 2,252,053 4.0% (+9,761 a/o 9-30-19 Nasdaq Inst.)
8. Altravue Capital 2,223,382 4.0% (+114,570 a/o 9-30-19 Nasdaq Inst.)
9. State Street 1,027,828 1.8% (+87,955 a/o 9-30-19 Nasdaq Inst.)
Inst. Holdings (Nasdaq) - updated 45-days after each qtr-end: http://www.nasdaq.com/symbol/cdmo/institutional-holdings
INSIDER-Trans: https://tinyurl.com/ycpw4j9z  (formerly PPHM thru 2017: http://tinyurl.com/ypkow8 )
Short Interest, updated twice a month: https://www.nasdaq.com/symbol/cdmo/short-interest
A-T-M (At-The-Market) Sales 3/2009 - 7/14/17 ($272,500,000gr./34,869,747sh=$7.81/sh): http://tinyurl.com/yagmu2on
PPHM shares were 1:7 Reverse Split eff. 7-10-17 (315mm/$.606=>45mm/$4.24) http://tinyurl.com/yymtzcm9
PPHM shares were 1:5 Reverse Split eff. 10-19-09 (~237mm/$.64=>~47.4mm/$3.20) http://tinyurl.com/ykuw588
Potential Value: 9-19-2017: Catalent acquires CDMO Cook Pharmica for $950M ($179Msales x 5.3; EV/EBITDA=17.3) http://tinyurl.com/yd46m8py

AVID TEAM: https://avidbio.com/team - Open Jobs: https://avidbio.applicantpro.com/jobs
1-8-20: Avid Appoints Timothy Compton as Chief Commercial Officer (repl. Tracy Kinjerski) https://tinyurl.com/ydww58sn

7-26-19: Catherine Mackey, PhD (ex Pfizer VP) joins Avid's BOD https://tinyurl.com/y3xhqmvm
5-8-19: Richard (Rick) B. Hancock named Interim President/CEO; Roger Lias resigns https://tinyurl.com/y4pqdwyc
7-16-18: Daniel Hart (ex-ENO Holdings) joins Avid as CFO https://tinyurl.com/ychz45p2
7-16-18: Michael Faughnan (ex-Lonza/WuXi Biologics) joins Avid as Sr.Dir./BusDev/WestC https://tinyurl.com/yaozdggz (Left 5-2019)
5-29-18: Sandra C. Carbonneau (ex-Lonza) joins Avid as Dir./BusDev./EastCoast https://tinyurl.com/ybvrwn2l
5-8-18: Magnus Schroeder (ex-AGC Biologics) joins Avid as VP/Process Sciences https://tinyurl.com/y7tpswaw
2-23-18: CFO Paul Lytle voluntarily resigns eff. 5-24-18 (2-23-18 +90days), "CFO search underway" https://tinyurl.com/ybnjzbv6
9-11-17: Roger J. Lias (ex-Allergan) to become Avid’s CEO and join PPHM’s BOD eff. 9-25-17 https://tinyurl.com/yddufw4s (left 5-8-19)
11-29-17: Tracy L. Kinjerski joins Avid as VP/Bus.Operations https://tinyurl.com/yc4zenkc (Left 1-8-2020)
Profiles of all 6 BOD members & Compensation as of 5-8-19: https://tinyurl.com/y9lkl4q2 (Lias left 5-8-19)
...Joseph Carleone/Chair, Richard Hancock, Gregory Sargen, Joel McComb, Mark Bamforth, Patrick Walsh

10-24-17: Peregrine Adds Patrick D. Walsh to BOD, "An Industry Veteran with 30+yrs Experience Leading Successful CDMO Org’s” http://tinyurl.com/y3jo2rv7
10-19-17: Peregrine Adds Mark R. Bamforth to BOD, "10yrs/Genzyme; 30yrs of biologics leadership experience, incl. founding 2 CDMOs" http://tinyurl.com/y6ydcaof

ANALYST COVERAGE: http://ir.avidbio.com/analyst-coverage
Janney Capital - Paul Knight (init. 6-25-18): Buy/PT=$10 https://www.janney.com Coverage: https://jms.bluematrix.com/docs/html/BLUE.html
H.C. Wainwright - Joseph Pantginis (init. 3-24-18) Buy/PT=$11 https://tinyurl.com/ya8hew4c Coverage: https://hcwco.com/services/research
First Analysis Securities - Steven Schwartz & Tracy Marshbanks (init. 3-13-18 https://tinyurl.com/yabgz2ff ): OverWgt/PT=$8
"In transition": Wells Fargo (init. 3-15-18 https://tinyurl.com/yae5bjn5 ): Outperform/PT=$3.50
"In transition": Noble Life Science Partners - Caroline Palomeque https://noblecapitalmarkets.com/life-science (init. 7-16-15); 12-12-17: Buy/PT=$10

FINANCIALS & BUSINESS DEV.:
3-10-20: CDMO's Revs & Burns By Qtr Table, FY07/Q1 thru FY20/Q3 (q/e 1-31-20): https://tinyurl.com/s9cmzmf

......Avid FY20 (fye 4-30-20) revenues guidance: $55-59M; committed backlog=$58mm at 1-31-2020.
7-8-19: Avid Signs New Top10 Global Pharma and Expands Existing Cust. Relationship https://tinyurl.com/yyq8zgb9
6-27-19: "The 5 new clients signed in late FY2018 contributed significantly to revenue diversification in FY2019." SEE CUST SPLITS for FY19: http://tinyurl.com/y5j4dlsv
4-24-18: ”In recent weeks, Avid has signed new agreements with 3 addl. undisclosed intl. drug dev. companies (that’s 4 thus far in CY2018)” https://tinyurl.com/y89whc8d
3-1-18: Acumen Pharm. selects Avid for Process Dev. & Mfg. of ACU193 (Alzheimer’s) https://tinyurl.com/y8jvwleq http://www.acumenpharm.com
2-21-18: Enzyvant selects Avid to commercially mfg. RVT-801 (Farber disease) https://tinyurl.com/yd5xhcx8 http://www.enzyvant.com
2-12-18: Peregrine’s Legacy PS-Targeting IP Sold to ONCOLOGIE INC. (Boston, CEO: Laura E. Benjamin) for $8M/upfront, $95M/milestones https://tinyurl.com/yam8gb3h
...NOTE: 2-13-18: Oncologie Licenses Mologen’s immunotherapeutic ‘lefitolimod’ (TLR9 agonist) https://tinyurl.com/y9z54f4x “ONCOLOGIE is backed by top-tier intl. investors and has the objective to dev. novel personalized medicines in the field of immuno-oncology."
2-28-17: Avid & Cook (acq. by Catalent 12-2017 for $950M; $179Msales x 5.3; EV/EBITDA=17.3) remain Halozyme's 2 CMO's (“working to scale-up/validate/qualify Avid II/Myford for Roche collab.”): http://tinyurl.com/h75teta

FACILITIES: https://avidbio.com/services/#state-art-facilities
10-8-19: Avid Announces Completion of Expansion of Process Dev. Capabilities & Labs https://tinyurl.com/y3hfwst9
...will “significantly accelerate Avid’s ability to drive efficient & rapid on-boarding of new cust. pgms progressing to mfg.”
4-24-18: Avid adding Process Dev. Labs, upgrading capabilities (in phases; total will be >6000sq; 1st one ready Q3CY18/Jul-Sep'18) https://tinyurl.com/y89whc8d
5-2017: Avid II (Myford) adds 2 MilliporeSigma Mobius 2,000L single-use bioreactors; total mfg. capacity now ">11,000L". http://tinyurl.com/ky7bmu4
5-10-17: Halozyme comments on Avid II(Myford) expansion in their 3-31-17/10Q pub. 5-9-17: http://tinyurl.com/mrl34uk
..."validation of the new facility is scheduled to end in Q2/2017… Once this new facility is approved, it will become the primary source for Roche of bulk rHuPH20.”
6-2-16: Corp.Update – Avid Expansion & Drug Development - http://tinyurl.com/zvmhqmr
3-7-16/Avid II: Formal Commissioning of Avid's New 40,000sq "Myford" Facility, “single-use/fully disposable” (potentially $40M addl revs) http://tinyurl.com/y5jmfpo3
12-10-15/Avid II: Avid Expansion into MYFORD Facility now GMP-run ready (potential +$40mm sales) - contemplating further expansion http://tinyurl.com/y539yut4
12-10-14: Avid to Double Mfg. Capacity(“Myford Expansion”) http://tinyurl.com/y2sqoy2u & http://tinyurl.com/kmdgq8t



PRESENTATIONS & ARTICLES: http://ir.avidbio.com/events.cfm
10-25-18/BioPharma: Roger Lias Interview, “Avid expansion to Triple Process Dev. Capacity” https://tinyurl.com/ybtuk29m
Sept2018/BioTechWEEK: Tracy Kinjerski (VP/BusOP) interview: Avid’s differentiators (6mins.) https://www.youtube.com/watch?v=x3tzo4pZivk
1-29-18: NobleCon14 - 14th Annual Inv. Conf., Ft.Laud. => Roger Lias' webcast/slideshow https://tinyurl.com/yanwk9yo
11-15-17/Outsourcing-Pharma: “How This R&D Company (Peregrine) is Transitioning to a Pure-Play CDMO: ‘Opportunities Are Almost Endless’" - Recap of interviews with Steve King & Avid Pres. Roger Lias http://tinyurl.com/y7dv9faz

CONFERENCE CALLS & ASM's:
3-10-20: Qtly. Conf. Call (Hancock/Hart/Compton) PR & Transcript https://tinyurl.com/s9cmzmf
12-9-19: Qtly. Conf. Call (Hancock/Hart/Kinjerski) PR & Transcript https://tinyurl.com/tfewuzc

9-5-19: Qtly. Conf. Call (Hancock/Hart/Kinjerski) PR & Transcript https://tinyurl.com/y6t8zfur
6-27-19: Qtly. Conf. Call (Hancock/Hart/Kinjerski) PR & Transcript https://tinyurl.com/y6zdjyu2
...Rick Hancock, "Most importantly, during Q4, the Company achieved positive income, generating cash from dev. & mfg. operations for the 1st time since the beginning of the CDMO transition (Jan'18)."
3-11-19: Qtly. Conf. Call (Lias/Hart) PR & Transcript http://tinyurl.com/yy6dvjvc
12-3-18: Qtly. Conf. Call (Lias/Hart//Kinjerski) PR & Transcript https://tinyurl.com/y9n374kp
10-4-18: ASM/2018 (@Myford Facility) - Roger Lias’ Slideshow & Attendee Report https://tinyurl.com/yctfzhlb
9-10-18: Qtly. Conf. Call (Lias/Hart) PR & Transcript https://tinyurl.com/y8oc6hx8
...Roger Lias, "During the qtr, we advanced the projects of our existing active clients and continue to engage with numerous potential new customers."
7-16-18: Qtly. Conf. Call (Lias/Kinjerski) PR & Transcript https://tinyurl.com/yaozdggz
...Roger Lias, “In a short period, we’ve established a targeted business dev. operation that is actively providing visibility for Avid Bioservices within our fast growing but competitive marketplace.”
3-12-18: Qtly. Conf. Call (Lias/Kinjerski/Lytle) PR & Transcript https://tinyurl.com/yakdl4wj
...Roger Lias, ”I'm pleased to be able to report that in a very short period of time we've generated significant interest from both emerging & growth biopharmaceutical players and from pharmaceutical multinationals. I'm confident that the plan we're executing will drive a considerable increase in backlog and the opportunity to further enhance capacity utilization in the future.”
......From the 3-12-18 PR: “At present, we are in late-stage negotiations with several potential new customers and expect to announce the executed agreements before the end of the FY[4-30-18].”
1-18-18: ASM/2017 (@Myford Facility) - Roger Lias’ Slideshow & Attendee Reports https://tinyurl.com/yca6enbr 12-7-17 PROXY/14A: https://tinyurl.com/y7qprpg9
12-11-17: Qtly. Conf. Call (Lias/Lytle) Transcript https://tinyurl.com/ybycb2s6
...Roger Lias, "the company is undergoing a broad-scale transformation, the goals of which are to shift complete focus to the Avid Bioservices CDMO business and the complete divestiture of all of Peregrine's legacy R&D assets, which include bavituximab."
9-11-17: Qtly. Conf. Call (King/Lias/Lytle) Transcript http://tinyurl.com/y9y8qdac
...Steve King: “For this reason, we have concluded that in order to best position Peregrine’s R&D assets for successful development, they should be advanced by a partner with the appropriate expertise and ample resources to invest in the necessary clinical trials. To that end, we have been working diligently towards the transformation of the overall business to becoming a pure-play CDMO, while assessing the best strategic options for the R&D assets that would allow stockholders to directly see the future value from their continued developments. By partnering & eliminating future R&D expenditures, we believe we are best positioning Avid for future growth. Through reinvestment & expansion, we believe we will attract new customers and extend current contracts that will help position Avid as a leading U.S. CDMO. We are moving forward expeditiously with strategic discussions as we recognize the need to move quickly both from the R&D & CDMO standpoints. We hope to bring this process to completion over the coming months and will update you on our progress.”
7-14-17: Qtly. Conf. Call (King/Shan/Lytle) Transcript http://tinyurl.com/yb4wulvu
...Steve King: “We are seriously considering the possibility of separating our 2 distinct businesses, Avid and R&D/PS-Targeting.”
3-13-17: Qtly. Conf. Call (King/Shan/Worsley/Lytle) Transcript http://tinyurl.com/grhwjvy
...Steve King: “We believe the recent improvement of stock price is a growing recognition of the value of Avid, and having the full value of the Avid business reflected in our stock price is a top priority.”
12-12-16: Qtly. Conf. Call (King/Shan/Hutchins/Lytle) Transcript http://tinyurl.com/hhn4gga
...Steve King: “Our goal is to bring the overall company to profitability within the next 18mos. We believe just the value of Avid Bioservices is far greater than our current market cap and is only growing in value."
10-13-16 ASM/2016: ATTENDEE Reports & Link to CEO Steve King's 35min/45slide webcast: http://tinyurl.com/jx7ouay



Feb. 2018: Peregrine Pharmaceuticals completed its Mid’17-Early’18 Transition to a Pure-Play CDMO
(Contract Development & Manufacturing Organization), Avid Bioservices, Inc. - CEO: Roger Lias.

**FULL PPHM=>CDMO Transition History (Ronin/SWIM): https://tinyurl.com/ybqvzwhg
1-8-17: Peregrine chgs. name to “Avid Bioservices, Inc.”; new ticker: “CDMO” (+CDMOP) https://tinyurl.com/y8vhjow4
2-12-18: Peregrine’s Legacy PS-Targeting IP Sold to ONCOLOGIE INC. (Boston, CEO: Laura E. Benjamin) for $8M/upfront, $95M/milestones https://tinyurl.com/yam8gb3h
...12-13-18/8-K: Overview of Oncologie sale: https://tinyurl.com/yab9c6cr
NOTE: “PS-targeting Exosome tech. not included; back to UTSW", see: https://tinyurl.com/yakdl4wj

Click here for an ARCHIVE of the History of Peregrine’s Anti-PS/Bavituximab Platform - MOA, Trials, and Activity over the years, from early 2000’s thru 2017, prior to being Sold to ONCOLOGIE:
https://tinyurl.com/y8pq4rhc
Of Interest (post Oncologie Sale):
4-20-18/AACR’18: MSKCC(LudwigCC) Tweets about 2 WolchokLAB/”PPHM” Anti-PS Posters https://tinyurl.com/ycgjhvqa
4-26-18: New Bavi+Keytruda/LIVER Ph2 IST Trial, Sponsor=UTSW, Collab=MERCK https://tinyurl.com/y7fd9vdb
6-7-18: Oncologie Obtains $16.5M Seed Funding Led by Pivotal bioVenture Partners China Fund https://tinyurl.com/ybrrbgg7
6-7-18/BioCentury: Laura Benjamin states, “Oncologie plans to begin a trial mid-summer '18 evaluating Bavi to treat HCC and a P-O-C trial in Gastric cancer in 1Q19/2Q19.” https://tinyurl.com/ycb8r7sm
12-3-18: During q/e 10-31-18, Avid sold remaining legacy R&D asset, r84(anti-VEGF), to Oncologie for $1.0M upfront. Avid is eligible to receive up to an addl. $21M in dev/reg./comm. milestones, and low to mid-single digit royalties on net sales upon commercialization of products utilizing r84 https://tinyurl.com/y9n374kp

CDMO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CDMO News: Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer 01/08/2020 08:05:10 AM
CDMO News: Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2020 and Recent Developments 12/09/2019 04:05:10 PM
CDMO News: Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock 12/04/2019 04:05:10 PM
CDMO News: Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2020 After Market Close on December 9, 2019 12/02/2019 08:05:10 AM
CDMO News: Avid Bioservices Names Richard Richieri as Chief Operations Officer 10/09/2019 12:30:00 PM
PostSubject
#333204  Sticky Note 3-10-20 Qtly CC-Transcript, PR(Q3FY20/qe1-31-20), Avid Revs History Table cjgaddy 03/11/20 05:09:28 PM
#332931  Sticky Note Total INST.+LARGE Holdings now 40,237,198 71.4% (12-31-19) cjgaddy 02/17/20 12:33:27 PM
#333461   I asked if they reduced the headcount to Roger1 04/05/20 06:51:45 PM
#333460   Something isn't right here. If the problem MusicBizExec 04/05/20 06:46:55 PM
#333459   agreed Roger. Too many defenders of this bigdumbandugly 04/05/20 05:44:17 PM
#333458   Just heard from Stephanie on a sunday no less. Roger1 04/05/20 02:39:25 PM
#333456   The answer concerning the fix of the problem bfiest 04/04/20 08:05:21 AM
#333455   I heard that results would be impacted this Roger1 04/04/20 07:02:12 AM
#333454   Plain and simple shorting across all small cap peregr 04/04/20 05:05:03 AM
#333453   It was a major malfunction in processing as peregr 04/04/20 05:00:36 AM
#333452   Roger, I was talking about the last quarterly call purpledawgs 04/04/20 02:46:15 AM
#333451   if you are watching action and semi intelligent horselover45 04/04/20 01:54:59 AM
#333450   Lawyers were needed for the previous management group. bfiest 04/03/20 06:25:29 PM
#333449   I think it's time to get lawyers involved. Roger1 04/03/20 05:20:30 PM
#333448   The equipment "problem/malfunction" is what I would consider westjtter 04/03/20 05:02:34 PM
#333447   Are you saying the equipment problem hasn't been Roger1 04/03/20 04:39:55 PM
#333446   I wonder if CDMO is applying for a purpledawgs 04/03/20 02:35:41 PM
#333445   where's my eyeroll emoji. bigdumbandugly 04/03/20 10:01:29 AM
#333444   CDMO really should be in the Catbird seat stoneroad 04/03/20 09:50:44 AM
#333443   Looks like a 50 K green candle at cheynew 04/02/20 03:09:35 PM
#333441   A primer on pharmaceutical grade water issues (its r622102675 04/02/20 09:53:17 AM
#333440   Pretty exciting. 36 shares total. cheynew 04/02/20 07:14:38 AM
#333439   Here's the link...he wrote a NY times op-ed r622102675 04/01/20 03:59:28 PM
#333438   Just saw this from a twitter link...a doc r622102675 04/01/20 03:55:07 PM
#333437   Strange way this thing trades...just gets whipsawed about westjtter 04/01/20 01:41:32 PM
#333436   down 10%. bigdumbandugly 04/01/20 12:43:38 PM
#333435   Last regular hours trade 141K. Much larger cheynew 03/31/20 08:16:12 PM
#333434   c'mon you know the drill. bigdumbandugly 03/31/20 07:00:52 PM
#333433   The weakness in the preferred surprises me. Threes 03/31/20 06:42:08 PM
#333432   Was todays price action just a little end westjtter 03/31/20 01:38:45 PM
#333431   Down 1% as of now! Apparently no Cubflyer1946 03/31/20 12:34:05 PM
#333430   Up 12% at the open today! DrRocker 03/31/20 09:35:08 AM
#333428   I almost bought some yesterday. Sorry to cheynew 03/31/20 08:24:42 AM
#333427   Feel sad for all the ARMN share holders. pandb5298 03/31/20 08:06:27 AM
#333426   Maybe a piece of that corona cheddar coming war0001 03/30/20 07:12:16 PM
#333425   Thanks For Posting Time&Sales #'s, InterestingTimes,Glta,Eom. 4OurRetirement 03/30/20 06:11:04 PM
#333424   Date/Time Price Shares Exch/Mkt 03/30/2020 17:40:35 EDT I 5.26 1 EDGX cheynew 03/30/20 06:06:12 PM
#333423   ThinkOrSwim Projecting Potential MarketMakerMove=+/-$0.948 Glta,eom. 4OurRetirement 03/30/20 05:57:04 PM
#333422   Fwiw, BID Above ClosingPrice In AfterHours. Glta,eom. 4OurRetirement 03/30/20 05:23:50 PM
#333421   And it should be said that you are aykayeh 03/30/20 04:30:26 PM
#333420   April's $5 options are trading or $.40 Munchy 03/30/20 03:17:57 PM
#333419   Any thoughts on where this is headed? cheynew 03/30/20 12:11:06 PM
#333418   I don't because I usually only surf to ArchieK 03/30/20 11:15:40 AM
#333417   are you using ublock or some kind of bigdumbandugly 03/30/20 10:46:55 AM
#333416   Thanks. I think this confirms there's something embedded ArchieK 03/30/20 10:37:35 AM
#333415   I am getting the same thing every so djohn 03/30/20 10:16:07 AM
#333414   ODD, That 33,824 ShareTrade WasCancelled, Then Replaced? Glta,eom. 4OurRetirement 03/30/20 09:14:44 AM
#333413   Single PreMarket BUY Of 33,824 Shares@$4.68, Glta,eom. 4OurRetirement 03/30/20 08:59:07 AM
#333412   More likely it's Brighthouse Financial. Munchy 03/29/20 07:02:59 AM
#333411   Brighthouse is now Spectrum. A cable company Munchy 03/28/20 06:04:23 PM
#333410   I'm thinking it's an ad or a cookie ArchieK 03/28/20 09:34:00 AM
#333409   if you think it's a virus... bigdumbandugly 03/28/20 09:21:10 AM
PostSubject